Ikerchem Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 10
Employees
  • Latest Deal Type
  • M&A

Ikerchem General Information

Description

Developer of drugs for the treatment of cancer. The company specializes in the design and synthesis of novel chemical entities (NCEs) with therapeutic applications in oncology. The company also provides contractual research and development.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Acquirer
Quimatryx
Primary Office
  • Paseo Mikeletegui 69
  • planta 3
  • 20009 San Sebastián
  • Spain
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ikerchem Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 00.000 Completed Profitable
3. Early Stage VC 14-Dec-2011 00.000 00.000 Completed Profitable
2. Early Stage VC 01-Jan-2008 $291K $627K Completed Startup
1. Seed Round 15-Jun-2007 $336K $336K 00.000 Completed Startup
To view Ikerchem’s complete valuation and funding history, request access »

Ikerchem Executive Team (3)

Name Title Board Seat Contact Info
Fernando Cossio Co-Founder & Scientific Director
David Myles Scientific Advisor
You’re viewing 2 of 3 executive team members. Get the full list »

Ikerchem Board Members (6)

Name Representing Role Since
Ana Arrieta Ph.D Self Co-Founder & Board Member 000 0000
Begoña Lecea Ph.D Self Co-Founder & Board Member 000 0000
Iñaki Maiztegui Self Board Member & Founding Partner 000 0000
Manuel Arrieta Self Board Member 000 0000
Pedro Miguel Etxenike Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Ikerchem Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ikerchem Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Basque Venture Capital Management Venture Capital Minority 000 0000 000000 0
Centro para el Desarrollo Tecnológico Industrial Government Minority 000 0000 000000 0
Empresa Nacional de Innovación Venture Capital Minority 000 0000 000000 0
Ministry of Economy Government Minority 000 0000 000000 0
Talde Private Equity Venture Capital Minority 000 0000 000000 0
To view Ikerchem’s complete investors history, request access »